ID: ALA3427781

Max Phase: Preclinical

Molecular Formula: C14H12BrClN2O2S2

Molecular Weight: 419.75

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=S(=O)(NCCc1c[nH]c2ccccc12)c1cc(Br)c(Cl)s1

Standard InChI:  InChI=1S/C14H12BrClN2O2S2/c15-11-7-13(21-14(11)16)22(19,20)18-6-5-9-8-17-12-4-2-1-3-10(9)12/h1-4,7-8,17-18H,5-6H2

Standard InChI Key:  GFFPHNCWJPRDOK-UHFFFAOYSA-N

Associated Targets(Human)

DNA repair protein RAD51 homolog 1 504 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 419.75Molecular Weight (Monoisotopic): 417.9212AlogP: 4.17#Rotatable Bonds: 5
Polar Surface Area: 61.96Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.57CX Basic pKa: CX LogP: 4.40CX LogD: 4.21
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.65Np Likeness Score: -1.18

References

1. Magee TV..  (2015)  Progress in discovery of small-molecule modulators of protein-protein interactions via fragment screening.,  25  (12): [PMID:25971770] [10.1016/j.bmcl.2015.04.089]
2. Johnson CN, Erlanson DA, Murray CW, Rees DC..  (2017)  Fragment-to-Lead Medicinal Chemistry Publications in 2015.,  60  (1): [PMID:27739691] [10.1021/acs.jmedchem.6b01123]

Source